Table 3. Hospital complications and outcomes in matched patients with carbapenem-sensitive and carbapenem-resistant Enterobacterales .
| Characteristic | N | Overall
n = 500 |
CRE
n = 250 |
CSE
n = 250 |
p value | |
|---|---|---|---|---|---|---|
| Invasive MV | 500 | 234 (47) | 132 (53) | 102 (41) | 0.007 | |
| Duration of hemodialysis | 144 | 13 (8 - 19) | 14 (8 - 21) | 13 (8 - 16) | 0.3 | |
| Duration of intravenous short-term catheter | 321 | 19 (10 - 28) | 19 (11 - 28) | 19 (10 - 28) | 0.8 | |
| Duration of invasive MV | 234 | 16 (6 - 26) | 15 (6 - 24) | 17 (7 - 27) | 0.3 | |
| Length of stay | ||||||
| ICU | 500 | 15 (7 - 28) | 17 (8 - 29) | 13 (5 - 27) | 0.04 | |
| Hospital | 500 | 31 (18 - 56) | 30 (20 - 54) | 31 (16 - 58) | 0.5 | |
| Mortality | ||||||
| ICU | 500 | 173 (35) | 106 (42) | 67 (27) | < 0.001 | |
| Hospital | 500 | 234 (47) | 138 (55) | 96 (38) | < 0.001 | |
| 30-day | 500 | 119 (24) | 77 (31) | 42 (17) | < 0.001 | |
| 60-day | 500 | 188 (38) | 116 (46) | 72 (29) | < 0.001 | |
CRE - carbapenem-resistant Enterobacterales ; CSE - carbapenem-susceptible Enterobacterales ; MV - mechanical ventilation; ICU - intensive care unit. Data are presented as n (%) or medians and interquartile ranges (25 - 75%).